Marker Therapeutics, Inc. (MRKR)
0.93
-0.08
(-7.92%)
USD |
NASDAQ |
Oct 13, 15:23
Marker Therapeutics Market Cap : 15.51M for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 12, 2026 | 16.84M |
| October 09, 2026 | 16.20M |
| October 08, 2026 | 15.84M |
| October 07, 2026 | 17.34M |
| October 06, 2026 | 16.84M |
| October 05, 2026 | 17.67M |
| October 02, 2026 | 17.51M |
| October 01, 2026 | 17.51M |
| September 30, 2026 | 17.84M |
| September 29, 2026 | 18.34M |
| September 28, 2026 | 18.76M |
| September 25, 2026 | 19.17M |
| September 24, 2026 | 19.84M |
| September 23, 2026 | 20.67M |
| September 22, 2026 | 20.34M |
| September 21, 2026 | 20.01M |
| September 18, 2026 | 19.67M |
| September 17, 2026 | 19.67M |
| September 16, 2026 | 19.01M |
| September 15, 2026 | 19.51M |
| September 14, 2026 | 19.51M |
| September 11, 2026 | 19.17M |
| September 10, 2026 | 20.01M |
| September 09, 2026 | 20.17M |
| September 08, 2026 | 21.34M |
| Date | Value |
|---|---|
| September 04, 2026 | 19.67M |
| September 03, 2026 | 20.67M |
| September 02, 2026 | 20.84M |
| September 01, 2026 | 21.68M |
| August 31, 2026 | 22.18M |
| August 28, 2026 | 22.84M |
| August 27, 2026 | 24.34M |
| August 26, 2026 | 24.18M |
| August 25, 2026 | 25.34M |
| August 24, 2026 | 25.01M |
| August 21, 2026 | 23.18M |
| August 20, 2026 | 20.34M |
| August 19, 2026 | 21.51M |
| August 18, 2026 | 19.17M |
| August 17, 2026 | 19.34M |
| August 14, 2026 | 19.01M |
| August 13, 2026 | 18.51M |
| August 12, 2026 | 19.34M |
| August 11, 2026 | 18.67M |
| August 10, 2026 | 19.17M |
| August 07, 2026 | 18.67M |
| August 06, 2026 | 18.67M |
| August 05, 2026 | 19.01M |
| August 04, 2026 | 20.51M |
| August 03, 2026 | 20.34M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.198B |
| Alnylam Pharmaceuticals, Inc. | 29.83B |
| Anika Therapeutics, Inc. | 272.08M |
| Savara, Inc. | 996.19M |
| Vericel Corp. | 2.050B |
Market Cap Related Metrics
| PS Ratio | 7.171 |
| Price to Book Value | 1.275 |
| Price | 0.93 |
| Earnings Yield | -51.69% |